For U.S. residents only. Non-U.S. residents Novartis Pharma US
Learn About Novartis
   
Learn About Clinical Trials
                                   
What is Lung Cancer?


Man and woman

NSCLC is a disease in which cancer cells form in the tissues of the lung. These cells multiply to form tumors in the lung and can spread to other parts of the body. NSCLC is said to be “advanced” when it has spread to the lymph nodes, the other lung, or other areas of the body.

 

Novartis Oncology is currently conducting a clinical trial to learn whether the study drug ASA404, when given together with paclitaxel and carboplatin, can improve survival in patients with advanced NSCLC compared with paclitaxel and carboplatin alone. Your physical state, changes in your cancer, and laboratory findings observed during the trial will determine if ASA404 is safe and effective in the treatment of advanced NSCLC.

 

Novartis Pharma US